Beginning his career in 1991, Paul Mampilly started as an assistant portfolio manager at Bankers Trust on Wall Street. His impressive skills and knowledge with hedge funds advanced his career to manage multimillion-dollar accounts at ING and Deutsche Bank. During his career at Kinetics Asset Management, Paul Mampilly increased the firm’s assets to $25 billion and averaging a 26% annual return. In the middle of the financial crisis in 2008 and 2009, Mampilly invested in the Templeton Foundation, growing a $50 million investment to $88 million in a year.
Retiring to spend more time with family, Paul Mampilly shifted his focus to help everyday people invest, instead of only the wealthy 1%. Mampilly founded two newsletters of Profits Unlimited and Extreme Fortunes. With increasing popularity of his newsletters, he is launching True Momentum, a research service in 2017. Directing the newsletters toward people of different backgrounds and incomes, Mampilly provides research that is affordable for the average American. Each of the newsletters are based on Mampilly’s close daily monitoring of the world and North American markets. Paul Mampilly’s recommendations undergo extensive research of up to 40 hours to provide readers with easy to understand example scenarios and financial knowledge.
Paying particular attention to trends as the Internet of Things and tracking the millennial generation helps Mampilly make possible recommendations. Consistently tracking and reading stocks gives Paul Mampilly the best knowledge and dedication toward his productive career. When recommending a stock, Mampilly looks for the negative opinions to help better his recommendations. Although Paul Mampilly attended college, he feels that if he could start again, he wouldn’t attend college. Instead, he would have liked to learn about Wall Street through hands-on experience and trial and error.
Paul Mampilly graduated from Montclair State University for a BBA in Finance and Accounting. He furthered his education with an MBA in Finance from Fordham Gabelli School of Business. While being promoted to multiple different positions on Wall Street, Mampilly learned his expertise to later create Capuchin Consulting in 2013. With a 47% return the first year with Profits Unlimited, Mampilly’s consulting firm gives investment ideas to potential investors.
Along with founding his successful investment newsletters, Paul Mampilly was an editor, author and analyst for Agora Financial’s FDA Trader. During his tenure at FDA Trader, $6 million in sales was generated and was the #1 source for biotech investment research for investors. Mampilly also wrote recommendations for Common Sense Publishing for a year as an analyst. From his recommendations for Common Sense Publishing, over $2.5 million was generated in product sales.
Learn more about Paul Mampilly: https://dailyreckoning.com/dont-miss-the-biggest-biotech-market-ever/